A Ranft
Overview
Explore the profile of A Ranft including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thiel U, Schober S, Ranft A, Gassmann H, Jabar S, Gall K, et al.
Bone Marrow Transplant
. 2021 Aug;
56(9):2320.
PMID: 34373590
No abstract available.
2.
Thiel U, Schober S, Ranft A, Gassmann H, Jabar S, Gall K, et al.
Bone Marrow Transplant
. 2021 Jan;
56(7):1550-1557.
PMID: 33514918
Patients with advanced Ewing sarcoma (AES) carry a poor prognosis. Retrospectively, we analyzed 66 AES patients treated with allogeneic stem cell transplantation (allo-SCT) receiving HLA-mismatched (group A, n = 39)...
3.
Bosma S, Rueten-Budde A, Lancia C, Ranft A, Dirksen U, Krol A, et al.
Pediatr Blood Cancer
. 2019 Aug;
66(11):e27943.
PMID: 31389188
Background: We investigated the effects of surgical margins, histological response, and radiotherapy on local recurrence (LR), distant metastasis (DM), and survival in Ewing sarcoma. Procedure: Disease evolution was retrospectively studied...
4.
Bosma S, Lancia C, Rueten-Budde A, Ranft A, Gelderblom H, Fiocco M, et al.
Sci Rep
. 2019 Jul;
9(1):11000.
PMID: 31358784
Accurate survival estimations in Ewing sarcoma are necessary to develop risk- and response adaptive treatment strategies allowing for early decision-making. We aim to develop an easy-to-use survival estimation tool from...
5.
Herzog J, von Klot-Heydenfeldt F, Jabar S, Ranft A, Rossig C, Dirksen U, et al.
Sarcoma
. 2016 Nov;
2016:7461783.
PMID: 27843394
. Preclinical data indicate that trabectedin followed by irinotecan has strong synergistic effects on Ewing sarcoma. This is presumably due to hypersensitization of the tumor cells to the camptothecin as...
6.
Bolling T, Braun-Munzinger G, Burdach S, Calaminus G, Craft A, Delattre O, et al.
Klin Padiatr
. 2015 May;
227(3):108-15.
PMID: 25985445
Curative therapies for Ewing sarcoma have been developed within cooperative groups. Consecutive clinical trials have systematically assessed the impact and timing of local therapy and the activity of cytotoxic drugs...
7.
Zollner S, Dirksen U, Jurgens H, Ranft A
Ann Oncol
. 2013 Jun;
24(9):2455-61.
PMID: 23761687
Background: Renal Ewing's sarcoma/primitive neuroectodermal tumor (ES/PNET) is extremely rare. Clinical symptoms are nonspecific presenting abdominal pain, palpable mass, and hematuria. Owing to advanced technology demonstrating the ES-specific EWS/ETS translocation,...
8.
Froeb D, Ranft A, Boelling T, Paulussen M, Klco-Brosius S, Jurgens H, et al.
Klin Padiatr
. 2012 Nov;
224(6):348-52.
PMID: 23143762
Purpose: Ewing Sarcoma (ES) of the hand or foot is a rare clinical condition. Due to the critical site, it is of major importance to choose an optimal procedure for...
9.
Grunewald T, Ranft A, Esposito I, da Silva-Buttkus P, Aichler M, Baumhoer D, et al.
Ann Oncol
. 2012 Feb;
23(8):2185-2190.
PMID: 22317770
Background: Ewing's sarcoma (ES) is the second most common bone or soft-tissue sarcoma in childhood and adolescence and features a high propensity to metastasize. The six-transmembrane epithelial antigen of the...
10.
Alldinger I, Schaefer K, Goedde D, Ottaviano L, Dirksen U, Ranft A, et al.
J Cancer Res Clin Oncol
. 2007 May;
133(10):749-59.
PMID: 17530287
Only few clinical factors predict the prognosis of patients with Ewing tumors. Unfavorable outcome is associated with primary metastatic disease, age > 15 years, tumor volume above 200 ml, and...